Most of the bio companies ARK invests in are US-based, and we do not believe tariffs will impact them. In fact, we view recent tariff policies as a tailwind accelerating the growth of the US biotech footprint. Research Analyst Nemo Marjanovic, PhD discusses our biotech strategy in this askARK.
Similar Posts
Iran war: Why the new supreme leader is a rebuke to Trump | DW News
There’s a new supreme leader in Iran – 56-year-old hardliner Mojtaba Khamenei will take over from…
Press Sec. TANKS Stock Market in Real Time Just by Talking About It
Watch: Billionaire Trump Donor PANICS, Eats His Words In Epic Fashionhttps://www.youtube.com/watch?v=Wvyl2ArzhRk White House Press Secretary Karoline…
World leaders give Trump the silent treatment as they lose trust in America
As the US and Iran try to come to terms on a peace deal to end…
Centre-left party leads far-right in Netherlands election exit poll
Exit polls in the Dutch general election show the result is too close to call.The pro-European,…
Bengaluru CEO Accident A Wake Up Call for India s Road Safety| Experts Weigh in | Nelamangala | CEO
Join Afrida Rahman Ali, Consulting Editor of Free Press Journal, as she discusses the road accident…
Investigators probe motive in National Guard shooting near White House
Investigators in Washington, DC are working to determine the motive behind a shooting that left two…
